Castleark Management LLC Catalent, Inc. Transaction History

Castleark Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $6.99 Million - $8.88 Million	-96,034 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $4.07 Million - $6.69 Million	-84,675 Reduced 46.86%	96,034 $7.04 Million
Q1 2020 May 13, 2020	SELL	$36.95 - $62.95 $162,210 - $276,350	-4,390 Reduced 2.37%	180,709 $9.39 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $1.19 Million - $1.43 Million	-25,306 Reduced 12.03%	185,099 $10.4 Million
Q3 2019 Nov 15, 2019	BUY	$47.45 - $58.05 $9,490 - $11,610	200 Added 0.1%	210,405 $10 Million
Q2 2019 Aug 13, 2019	BUY	$39.26 - $54.21 $8.25 Million - $11.4 Million	210,205 New	210,205 $11.4 Million
Q2 2018 Aug 15, 2018	SELL	$38.72 - $42.52 $12.3 Million - $13.5 Million	-316,391 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $1.55 Million - $1.87 Million	-39,364 Reduced 11.06%	316,391 $13 Million
Q4 2017 Feb 15, 2018	SELL	$37.27 - $43.02 $54,973 - $63,454	-1,475 Reduced 0.41%	355,755 $14.6 Million
Q3 2017 Nov 15, 2017	BUY	$33.75 - $41.67 $12.1 Million - $14.9 Million	357,230	357,230 $14.3 Million

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.